Inherited C3 deficiency of the complement system. 1988

A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
Instituto da Criança Prof. Pedro de Alcantara, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Brasil.

1. We report a patient homozygous for C3 deficiency and several heterozygotes from the same family. Upon follow-up, the homozygote was found to suffer several severe bacterial infections, whereas all the heterozygotes were clinically healthy. 2. C3 was undetectable in the homozygous patient, CH50 was very low and factor I was present. Serum capacity to generate chemoattractant stimuli for peripheral leucocytes was similar to that of normal adults as was also observed for one of the heterozygotes. Serum capacity to opsonize yeast was reduced in the presence of autologous and homologous (normal adult) cells. The CH50 levels of heterozygous patients were within the lower range of normality. 3. The parental consanguinity and the homozygosis state observed here are classical signs of recessive autosomal inheritance. However, the lower or below normal C3 levels detected in parents and relatives point to a co-dominant inheritance of gene S with respect to the "null" gene. 4. C3 polymorphism presented a predominantly "slow" pattern in most family members, which, together with the low C3 levels, indicates the expression of S-allotypes.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003241 Consanguinity The magnitude of INBREEDING in humans. Inbreeding, Human,Consanguineous Marriage,Consanguinous Mating,Consanguineous Marriages,Consanguinities,Consanguinous Matings,Human Inbreeding,Human Inbreedings,Inbreedings, Human,Marriage, Consanguineous,Marriages, Consanguineous,Mating, Consanguinous,Matings, Consanguinous

Related Publications

A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
July 1994, European journal of immunology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
December 1996, Clinical immunology and immunopathology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
January 1986, European journal of immunology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
November 1994, The Journal of biological chemistry,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
January 1995, Immunology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
June 2001, Molecular biotechnology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
February 1984, British journal of rheumatology,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
January 2004, Bulletin et memoires de l'Academie royale de medecine de Belgique,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
January 2016, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne,
A S Grumach, and M M Vilela, and C H Gonzalez, and N Starobinas, and A B Pereira, and W Dias-da-Silva, and M M Carneiro-Sampaio
April 1982, Clinics in rheumatic diseases,
Copied contents to your clipboard!